黏液性卵巢癌诊断与治疗中国专家共识(2021年版)

2021-07-19 妇产科相关专家组(统称) 中国微创外科杂志. 2021,21(07)

黏液性卵巢癌(mucinous ovarian cancer, MOC)是上皮性卵巢癌(epithelial ovarian carcinoma, EOC)的组织学亚型之一,占EOC 3%~5%,具有

中文标题:

黏液性卵巢癌诊断与治疗中国专家共识(2021年版)

发布日期:

2021-07-19

简要介绍:

黏液性卵巢癌(mucinous ovarian cancer, MOC)是上皮性卵巢癌(epithelial ovarian carcinoma, EOC)的组织学亚型之一,占EOC 3%~5%,具有独特的临床、组织病理学和分子生物学特征,常见于中青年女性,多认为MOC由交界性黏液性肿瘤恶变而来,典型表现为单侧卵巢巨大、单房或多房性囊肿,内充满黏液。早期MOC预后较好,晚期MOC对化疗不敏感,预后较差。手术是MOC主要治疗手段,早期患者施行全面分期手术,晚期患者需要接受肿瘤细胞减灭术,力争达到无残留病灶(R0)。手术方式首选开腹手术,有生育要求的Ⅰ期MOC可施行保留生育功能的分期手术。ⅠA~ⅠB期患者术后可观察,ⅠC期患者可选择化疗或观察;Ⅱ期及以上患者需辅助以铂类为基础联合化疗或参考胃肠型肿瘤化疗方案,腹腔热灌注化疗(hyperthermic intraperitoneal chemotherapy, HIPEC)可提高缓解率。复发性MOC的二次减瘤术存有争议。VEGF抑制剂、EGFR单抗、抗HER2治疗是未来探索的方向。 
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=黏液性卵巢癌诊断与治疗中国专家共识_2021年版_张德普.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2067a1c0021398ca, title=黏液性卵巢癌诊断与治疗中国专家共识(2021年版), enTitle=, guiderFrom=中国微创外科杂志. 2021,21(07), authorId=0, author=, summary=黏液性卵巢癌(mucinous ovarian cancer, MOC)是上皮性卵巢癌(epithelial ovarian carcinoma, EOC)的组织学亚型之一,占EOC 3%~5%,具有, cover=https://img.medsci.cn/2021729/1627488541936_2020535.jpg, journalId=0, articlesId=null, associationId=922, associationName=妇产科相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jul 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">黏液性卵巢癌(mucinous ovarian cancer, MOC)是上皮性卵巢癌(epithelial ovarian carcinoma, EOC)的组织学亚型之一,占EOC 3%~5%,具有独特的临床、组织病理学和分子生物学特征,常见于中青年女性,多认为MOC由交界性黏液性肿瘤恶变而来,典型表现为单侧卵巢巨大、单房或多房性囊肿,内充满黏液。早期MOC预后较好,晚期MOC对化疗不敏感,预后较差。手术是MOC主要治疗手段,早期患者施行全面分期手术,晚期患者需要接受肿瘤细胞减灭术,力争达到无残留病灶(R0)。手术方式首选开腹手术,有生育要求的Ⅰ期MOC可施行保留生育功能的分期手术。ⅠA~ⅠB期患者术后可观察,ⅠC期患者可选择化疗或观察;Ⅱ期及以上患者需辅助以铂类为基础联合化疗或参考胃肠型肿瘤化疗方案,腹腔热灌注化疗(hyperthermic intraperitoneal chemotherapy, HIPEC)可提高缓解率。复发性MOC的二次减瘤术存有争议。VEGF抑制剂、EGFR单抗、抗HER2治疗是未来探索的方向。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=113754, tagName=黏液性卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=359, guiderKeyword=卵巢癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20308, appHits=285, showAppHits=0, pcHits=2535, showPcHits=20011, likes=0, shares=42, comments=8, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-07-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 29 00:09:16 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 21:10:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=黏液性卵巢癌诊断与治疗中国专家共识_2021年版_张德普.pdf)])
黏液性卵巢癌诊断与治疗中国专家共识_2021年版_张德普.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192694, encodeId=dcb51192694d8, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27fe6500495, createdName=ms2000002016332485, createdTime=Sat Feb 12 16:32:20 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070078, encodeId=f31510e007814, content=非常感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:58:20 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055492, encodeId=5939105549282, content=属于上皮性一种?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31a5540845, createdName=汤汤汤堂躺趟, createdTime=Mon Sep 27 21:09:56 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011881, encodeId=95b21011881e3, content=刚好一个IC期患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35215391000, createdName=ms9000001166668150, createdTime=Fri Aug 27 02:03:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011560, encodeId=1792101156015, content=中文2021版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/0b0f277058a1465591de978dcbc62643/f97b08d909c4499ab545439b205f041f.jpg, createdBy=03155581907, createdName=ms1000001611358836, createdTime=Thu Aug 26 00:38:56 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2022-02-12 ms2000002016332485

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192694, encodeId=dcb51192694d8, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27fe6500495, createdName=ms2000002016332485, createdTime=Sat Feb 12 16:32:20 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070078, encodeId=f31510e007814, content=非常感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:58:20 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055492, encodeId=5939105549282, content=属于上皮性一种?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31a5540845, createdName=汤汤汤堂躺趟, createdTime=Mon Sep 27 21:09:56 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011881, encodeId=95b21011881e3, content=刚好一个IC期患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35215391000, createdName=ms9000001166668150, createdTime=Fri Aug 27 02:03:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011560, encodeId=1792101156015, content=中文2021版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/0b0f277058a1465591de978dcbc62643/f97b08d909c4499ab545439b205f041f.jpg, createdBy=03155581907, createdName=ms1000001611358836, createdTime=Thu Aug 26 00:38:56 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-11-14 陌上咖啡

    非常感谢!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192694, encodeId=dcb51192694d8, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27fe6500495, createdName=ms2000002016332485, createdTime=Sat Feb 12 16:32:20 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070078, encodeId=f31510e007814, content=非常感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:58:20 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055492, encodeId=5939105549282, content=属于上皮性一种?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31a5540845, createdName=汤汤汤堂躺趟, createdTime=Mon Sep 27 21:09:56 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011881, encodeId=95b21011881e3, content=刚好一个IC期患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35215391000, createdName=ms9000001166668150, createdTime=Fri Aug 27 02:03:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011560, encodeId=1792101156015, content=中文2021版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/0b0f277058a1465591de978dcbc62643/f97b08d909c4499ab545439b205f041f.jpg, createdBy=03155581907, createdName=ms1000001611358836, createdTime=Thu Aug 26 00:38:56 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-09-27 汤汤汤堂躺趟

    属于上皮性一种?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1192694, encodeId=dcb51192694d8, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27fe6500495, createdName=ms2000002016332485, createdTime=Sat Feb 12 16:32:20 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070078, encodeId=f31510e007814, content=非常感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:58:20 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055492, encodeId=5939105549282, content=属于上皮性一种?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31a5540845, createdName=汤汤汤堂躺趟, createdTime=Mon Sep 27 21:09:56 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011881, encodeId=95b21011881e3, content=刚好一个IC期患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35215391000, createdName=ms9000001166668150, createdTime=Fri Aug 27 02:03:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011560, encodeId=1792101156015, content=中文2021版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/0b0f277058a1465591de978dcbc62643/f97b08d909c4499ab545439b205f041f.jpg, createdBy=03155581907, createdName=ms1000001611358836, createdTime=Thu Aug 26 00:38:56 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-27 ms9000001166668150

    刚好一个IC期患者

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1192694, encodeId=dcb51192694d8, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=27fe6500495, createdName=ms2000002016332485, createdTime=Sat Feb 12 16:32:20 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070078, encodeId=f31510e007814, content=非常感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=陌上咖啡, createdTime=Sun Nov 14 09:58:20 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055492, encodeId=5939105549282, content=属于上皮性一种?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a31a5540845, createdName=汤汤汤堂躺趟, createdTime=Mon Sep 27 21:09:56 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011881, encodeId=95b21011881e3, content=刚好一个IC期患者, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35215391000, createdName=ms9000001166668150, createdTime=Fri Aug 27 02:03:58 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011560, encodeId=1792101156015, content=中文2021版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/0b0f277058a1465591de978dcbc62643/f97b08d909c4499ab545439b205f041f.jpg, createdBy=03155581907, createdName=ms1000001611358836, createdTime=Thu Aug 26 00:38:56 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 ms1000001611358836

    中文2021版

    0

拓展阅读

2010ESMO临床实践指南:非上皮性卵巢癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2011 NICE 卵巢癌的诊断和起始治疗

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011 NICE Trabectedin治疗复发性卵巢癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2012 ESMO临床实践指南:非上皮性卵巢癌的诊治与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 NSGC实践指南:遗传性乳腺癌和卵巢癌的风险评估和遗传咨询

国家遗传咨询师学会(NSGC,National Society of Genetic Counselors) · 2012-11-28

2013 FIGO 卵巢癌、输卵管癌、腹膜癌分期指南

国际妇产科联盟(FIGO,International Federation of Gynecology and Obstetrics) · 2013-10-22